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Zusammenfassung
Der zytotoxisch nekrotisierende Faktor 1 (CNF1) aus uropathogenen Escherichia coli
Stmmen (UPEC) aktiviert die niedermolekularen GTP-bindenden Proteine RhoA, 
Rac1 und Cdc42. Dies hat eine Reorganisation des Aktinzytoskeletts und Polyploidie
zur Folge. Diese Arbeit basiert auf der Hypothese, dass die Aktivierung von Rac1 
durch CNF1 eine Hochregulation des „immediate early gene“ Produkts RhoB bewirkt.
RhoB unterdrckt mglicherweise die CNF1-induzierte Polyploidie.
Die ektopische Expression von konstitutiv aktivem Rac1 sowie die Aktivierung von
endogenem Rac1 durch CNF1 aktivierten den rhoB Promotor. Die Aktivierung des
rhoB Promotors durch CNF1 hatte eine Hochregulation des rhoB mRNA- und RhoB 
Proteinspiegels zur Folge. Mit Hilfe des Rac1 Inhibitors NSC23766 konnte besttigt 
werden, dass die CNF1-induzierte RhoB Hochregulation auf der Aktivierung von 
Rac1 beruhte. c-Myc und die p38 MAP Kinase werden von Rac1 reguliert. Beide 
waren in die CNF1-induzierte RhoB Hochregulation eingeschaltet. c-Myc verstrkte
die RhoB Hochregulation, whrend p38 eine supprimierende Wirkung auf die CNF1-
induzierte RhoB Antwort hatte. In CNF1-behandelten Zellen stieg der RhoB Spiegel
fr mindestens 48 h an, obwohl RhoB eine kurze Halbwertzeit (< 1 h) besa. 
Anscheinend wurde die RhoB Expression in CNF1-behandelten Zellen langanhaltend 
stimuliert. Die RhoB Hochregulation ging mit dessen Aktivierung einher.
Die Behandlung von NIH3T3, ME Fibroblasten und humanen Kolonozyten (HCT 116)
mit CNF1 fhrte zur Polyploidie. Die CNF1-induzierte Polyploidie knnte mit 
folgendem Modell erklrt werden: Der Abschluss der Zytokinese erfordert die 
Inaktivierung von RhoA durch Mgc GAP. Die Deamidierung verhindert die Mgc-
vermittelte RhoA Inaktivierung, was den Abschluss der Zytokinese verhindert. Dies 
fhrt zur Polyploidie. 
Es wurde vorgeschlagen, dass p53 einen Zellzyklusarrest in tetraploiden Zellen 
auslst (“Tetraploidie Kontrollpunkt”). p53 verhinderte die CNF1-vermittelte 
Polyploidie nicht, da diese in p53 WT und p53 -/- HCT 116 Zellen mit vergleichbarer 
Kinetik ablief. Dieses Ergebnis steht im Widerspruch zu der Existenz eines durch p53 
regulierten Tetraploidie Kontrollpunktes. RhoB unterdrckte die CNF1-induzierte
Polyploidie, da diese in RhoB -/- ME Fibroblasten gegenber RhoB +/- und NIH3T3 
Fibroblasten verstrkt war. CNF1 wird hufig als anti-apoptotischer Faktor
beschrieben. CNF1-Behandlung fhrte in RhoB -/- Fibroblasten zum apoptotischen 
Zelltod, jedoch nicht in RhoB +/- oder NIH3T3 Fibroblasten. Dieser Befund legte den 
Schluss nahe, dass RhoB fr das berleben der CNF1-behandelten Zielzelle 
bentigt wird.
Die Inhibition der Zytokinese durch CNF1 verlangsamt mglicherweise die 
Erneuerung von Epithelzellen des Ureters, was die Kolonisierung durch CNF1-
produzierenden E. coli begnstigt.
Schlagworte: zytotoxisch nekrotisierender Faktor; RhoB; Polyploidie
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Abstract
The cytotoxic necrotizing factor 1 (CNF1) from uropathogenic Escherichia coli
(UPEC) activates the low molecular weight GTP-binding proteins RhoA, Rac1, and 
Cdc42. Thereby, CNF1 causes actin re-organisation and polyploidy. This study is 
based on the hypothesis that Rac1 activation by CNF1 causes up-regulation of the 
immediate early gene product RhoB. RhoB may suppress CNF1-incuced polyploidy.
Ectopic expression of constitutively active Rac1 and activation of endogenous Rac1 
by CNF1 caused activation of the rhoB promoter. The rhoB promoter activation 
induced by CNF1 was reflected by an increase of the rhoB mRNA and RhoB protein
level. Inhibition of Rac1 by NSC23766 confirmed that CNF1-induced RhoB up-
regulation was based on Rac1 activation. c-Myc and p38 MAP kinase are 
downstream effectors of Rac1. Both were involved in CNF1-induced RhoB up-
regulation. c-Myc positively, while p38 negatively regulated the RhoB response. In 
CNF1-treated cells, the level of RhoB was elevated for at least 48 h, even though 
RhoB exhibited a short half-life period (< 1 h). Thus, RhoB up-regulation was
permanently triggered by CNF1 for at least 48 h. Up-regulated RhoB was active in 
CNF1-treated cells, as determined by effector pulldown assay.
Treatment with CNF1 caused polyploidy in NIH3T3 and ME fibroblasts, as well as in 
the human colon carcinoma cell line HCT 116. We suggest the following model for
CNF1-induced polyploidy: Completion of cytokinesis requires the inactivation of 
RhoA by Mgc GAP. Deamidation blocks the Mgc-induced inactivation of RhoA, 
leading to blocked cytokinesis, which results in polyploidy.
p53 has been suggested to induce cell cycle arrest of tetraploid cells (“tetraploidy 
checkpoint”). Polyploidy was not suppressed by p53, as the kinetics of CNF1-induced 
polyploidy were comparable in p53 WT and p53 -/- HCT 116 cells. Our data 
challenge the existence of a p53-dependent tetraploidy checkpoint. RhoB was a 
suppressor of polyploidy, as CNF1-induced polyploidy was enhanced in RhoB -/-
compared to either MEF RhoB +/- or NIH3T3 fibroblasts. CNF1 is often characterised 
as anti-apoptotic. In MEF RhoB -/- but not in MEF RhoB +/- or NIH3T3 fibroblasts, 
CNF1 induced apoptotic cell death. Thus, RhoB is required for the survival of the 
CNF1-treated mammalian target cells.
Inhibition of cytokinesis by CNF1 may inhibit cell renewal, resulting in prolonged 
colonisation of adherent uropathogenic bacteria in the epithel. 
Keywords: cytotoxic necrotizing factor; RhoB; polyploidy
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1 Introduction
1.1 Low molecular weight GTP-binding proteins 
The Ras (Rat sarcoma) superfamily of low molecular weight GTP-binding proteins 
consists of more than 150 members (molecular weight: 18-26 kDa). Based on 
structural, sequential, and functional similarities, the Ras superfamily has been 
divided into 5 subfamilies: Ras, Rho, Rab, Ran, and Arf (Table I) (Wennerberg et al., 
2005). GTP-binding proteins are molecular switches that cycle between an inactive, 
GDP-bound, and an active, GTP-bound, conformation (Hall and Nobes, 2000). The 
GTPase cycle of low molecular weight GTP-binding proteins (shown for Rho) is 
regulated by two groups of proteins (Fig. I) (Jaffe and Hall, 2005):
1. Guanine nucleotide exchange factors (GEFs) stimulate the exchange of GDP 
against GTP, thereby activating GTP-binding proteins.
2. GTPase activating proteins (GAPs) potentiate the intrinsic GTPase activity. GTP 
hydrolysis causes inactivation of the Ras proteins.
Rho and Rab proteins are further regulated by guanine nucleotide dissociation
inhibitors (GDIs). GDIs stabilise the inactive, GDP-bound, conformation of Rho and 
Rab proteins in the cytosol (Olofsson, 1999). 
The exchange of GDP against GTP causes conformational changes in the switch I 
region (residues 32–40 in RhoA) and switch II region (residues 62-78 in RhoA)
(Wittinghofer and Pai, 1991; Fujisawa et al., 1998). The switch I is critical for effector-
binding and the switch II for GTP hydrolysis. The conformational changes allow the 
interaction of Ras proteins with their effectors. Effectors of GTP-binding proteins
include serine/threonine/tyrosine kinases, lipid kinases, lipases, oxidases, and 
scaffold proteins (Jaffe and Hall, 2005).
An important biochemical feature of the majority of low molecular weight GTP-binding
proteins is their post-translational modification (Wennerberg et al., 2005). Most Ras 
proteins are isoprenylated at the C-terminal CAAX (C=Cys, A=aliphatic, X=any amino 
acic) motif (Cox and Der, 2002). Isoprenylation at the cysteine residue within the 
CAAX-motif by either geranylgeranyl-transferases (GGT) or farnesyl-transferases
1 Introduction
- 2 -
(FT) facilitates membrane targeting and is thus required for subcellular localisation of 
the Ras proteins (Wennerberg et al., 2005). GDIs mask the isoprenyl moiety of Rho 
and Rab proteins to prevent membrane targeting (Wennerberg et al., 2005).
Table I: Functions of the 5 subfamilies of the Ras superfamily of low molecular weight proteins
RhoGDP RhoGTP
effector
GTP GDP
GEF
stimulus
P i
RhoGDP
GDI
GAP
 actin dynamics
 gene transcription
 cell cycle progression
 apoptosis
Fig. I: The GTPase cycle of Rho proteins
Rho proteins cycle between an inactive, GDP-bound, and an active, GTP-bound, conformation. In the 
GTP-bound conformation, they interact with their effector proteins to regulate signal transduction. The 
GTPase cycle is regulated by guanine nucleotide exchange factors (GEF, activating), GTPase 
activating proteins (GAP, inactivating), and guanine nucleotide dissociation inhibitors (GDI, 
inactivating) (adapted from Jaffe and Hall, 2005).
gene expression, cell differentiation, cell proliferation
actin cytoskeleton, cell cycle progression, gene expression
transport of proteins and vesicles
transport of proteins and vesicles
nucleocytoplasmic transport of RNA and proteins
Ras
Rho
Rab
Arf
Ran
regulation ofsubfamily
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1.2 Rho proteins
The Rho (Ras homologous) subfamily consists of 23 members: Rho(A,B,C),
Rac(1,2,3), RhoG/AhrG, Cdc42, TC10, TCL, Wrch-1, Wrch-2/Chp, RhoH/TTF, Rnd1,
Rnd2, RhoE/Rnd3, RhoD/AhrD, RhoF/Rif, as well as the atypical Rho proteins:  
RhoBTB(1,2,3), and Miro-1 and 2 (Bustelo et al., 2007). 
Rho family proteins regulate the actin cytoskeleton, cell-cycle progression, gene 
transcription, and vesicle trafficking (Jaffe and Hall, 2005). The best studied Rho 
family proteins are RhoA, Rac1, and Cdc42. They are described as key regulating 
proteins of the actin cytoskeleton (Wennerberg and Der, 2004). RhoA activation 
induced by lysophosphatidic acid (LPA) causes the formation of stress fibres in 
fibroblasts (Hall, 1998). At the plasma membrane, stress fibres end in focal 
adhesions, which connect the actin cytoskeleton with the extracellular matrix (Ridley 
and Hall, 1994). Moreover, RhoA-induced stress fibres are required for the formation 
of the contractile ring during cytokinesis (Wadsworth, 2005). Activation of Rac1 by 
platelet-derived growth factor (PDGF) or insulin leads to the assembly of actin 
filaments at the cell periphery, namely lamellipodia and membrane ruffles (Hall, 
1998). Active Cdc42 is responsible for the formation of actin-based surface 
protrusions called filopodia (Nobes and Hall, 1995). Consequently, RhoA, Rac1, and 
Cdc42 regulate cell polarity, cell shape, cell movement, and cell-cell-interactions 
(Ridley, 2001).
1.3 RhoB
RhoA and RhoB are 86 % identical at the amino acid level. Both are involved in the 
regulation of the actin cytoskeleton. They interact with the same GEF and effector 
proteins (Wennerberg and Der, 2004). RhoB, however, displays several properties 
distinct from RhoA. While RhoA is constitutively expressed, RhoB is transcriptionally 
regulated. The RhoB expression is low in quiescent cells due to RhoA- and 
(H/K/N)Ras-dependent suppression of the rhoB promoter activity (Jiang et al., 2004).
RhoB up-regulation occurs physiologically during G1- and S-phase (Zalcman et al., 
1995). Furthermore, RhoB is up-regulated in response to genotoxic stress and 
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growth factors and is thus classified as an immediate early gene product. (Fritz and 
Kaina, 2001; Jhner and Hunter, 1991). Inactivation of RhoA or (H/K/N)Ras by either 
farnesyl-transferase/geranylgeranyl-transferase inhibitors (Stamatakis et al., 2002) or 
Rho/Ras-inactivating bacterial protein toxins (Gerhard et al., 2005; Huelsenbeck et 
al., 2007) causes “de-suppression” of the rhoB promoter, resulting in RhoB up-
regulation. RhoB can be either farnesylated (RhoB-F) or geranylgeranylated (RhoB-
GG), and is additionally modified by palmitic acid (Adamson et al., 1992a). Opposing 
functions of RhoB have been suggested to be based on the nature of RhoB 
prenylation (Mazieres et al., 2005). RhoB-F is associated with the plasma membrane,
whereas RhoB-GG localises to endomembrane vesicles (endosomes and 
lysosomes) (Adamson et al., 1992b) (Michaelson et al., 2001). The distinct 
subcellular localisation may be responsible for the distinct biological activities of 
RhoB-F and RhoB-GG (Mazieres et al., 2005). RhoB regulates the transport of 
endosomes (Rojas et al., 2004) and causes G2-arrest after UV-light exposure (Milia 
et al., 2005). Furthermore, RhoB contributes to the initiation of apoptosis by alkylating 
mutagens and toxin B from Clostridium difficile (Fritz and Kaina, 2000; Huelsenbeck
et al., 2007). Several studies, however, show a protective role of RhoB against cell 
death (Ader et al., 2002; Canguilhem et al., 2005). RhoB-F has been shown to 
suppress multinucleation and centrosome overduplication in cells exposed to UV-
light to prevent mitotic cell death (Milia et al., 2005). Accordingly, RhoB has been 
proposed to participate in the decision of a damaged cell to undergo cell death or to 
initiate repair mechanisms rather than to regulate cell death itself (Fritz and Kaina, 
2000).
1.4 Rho-modifying bacterial pathogenicity factors
A variety of bacterial pathogenicity factors targets Rho proteins to manipulate host-
cell functions. These factors can be divided into two subgroups: Rho-inactivating and 
Rho-activating pathogenicity factors. 
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1.5 Rho-inactivating bacterial pathogenicity factors 
C3 exoenzyme from Clostridium botulinum (C3bot) was the first pathogenicity factor 
identified as Rho-inactivating. C3bot specifically ADP-ribosylates Rho(A,B,C) at 
asparagine 41 using the co-substrate NAD+ (Sekine et al., 1989). This modification
renders Rho(A,B,C) inactive, as it blocks the GEF-mediated nucleotide exchange 
(Sehr et al., 1998) and promotes binding of the GTP-binding proteins to their GDI 
proteins (Genth et al., 2003). The clostridial glucosylating toxins (CGT), e.g., toxin A 
(TcdA) and toxin B (TcdB) from Clostridium difficile and lethal toxin (TcsL) from 
Clostridium sordellii, are further inactivating toxins. They catalyse the transfer of a
glucose moiety from their co-substrate UDP-glucose onto a pivotal threonine residue 
(Thr37 in RhoA, Thr35 in Rac1) within the switch I domain of Rho/Ras proteins (Just 
et al., 1995a; Just et al., 1995b; Just et al., 1996; Popoff et al., 1996). The 
glucosylation blocks the interaction of Rho/Ras proteins with their effector proteins,
thereby causing their functional inactivation (Sehr et al., 1998; Genth et al., 1999; 
Hermann et al., 1998). 
1.6 Rho-activating bacterial pathogenicity factors 
Rho-activating protein toxins have been isolated exclusively from gram-negative 
bacteria (Lemonnier et al., 2007): the cytotoxic necrotizing factors (CNFs) CNF1, 
CNF2, and CNF3 from Escherichia coli, CNFY from Yersinia pseudotuberculosis, and 
the dermonecrotic toxin (DNT) from Bordetella species. The first identified toxin was 
CNF1, which was isolated from enteritis-affected children (Caprioli et al., 1983). The 
toxin is cytotoxic for HeLa cells and exhibits a necrotizing effect on skin when 
injected subcutaneously in rabbits, mice, or guinea pigs. Based on these effects, it 
was called cytotoxic necrotizing factor (Caprioli et al., 1983). About 60 % of 
uropathogenic E. coli strains (UPECs) carry the cnf1 gene. Mutation of this gene 
attenuates the virulence of UPECs (Rippere-Lampe et al., 2001). These observations 
indicate that CNF1 plays a role in UPEC-mediated urinary tract infection. CNFY is one 
of many pathogenicity factors of Yersinia pseudotuberculosis (Lockman et al., 2002). 
Its role in pathogenicity is unclear. 
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1.7 Structure and up-take mechanism of CNF1 and CNFY
The chromosomally located cnf1 and cnfY genes encode single-chained proteins with 
molecular masses of about 115 kDa (Falbo et al., 1993; Lockman et al., 2002). Both 
are 65 % identical at the nucleotide level (Lockman et al., 2002). CNF1 and CNFY are 
multi-domain protein toxins. They can be classified as A-B toxins with a C-terminal 
deamidase domain and an N-terminal delivery domain (Fig. II). The delivery domain 
harbours the receptor binding domain (amino acids (aa) 53-190) (Hoffmann and 
Schmidt, 2004). The cellular receptor of CNF1 has been suggested to be the laminin 
receptor precursor p37, a subunit of the mature non-integrin 67 kDa laminin receptor. 
In a yeast two-hybrid system, CNF1 has been shown to bind to the ubiquitously 
expressed p37 (Chung et al., 2003; Kim et al., 2005). CNFY binds to a different 
cellular receptor. Recent data, however, suggested overlapping regions of the 
receptors for CNF1 and CNFY (Blumenthal et al., 2007). Possible candidates,
exhibiting overlapping structures, are heparan sulfate proteoglycans (HSPGs) 
(Blumenthal et al., 2007). Receptor binding of CNFs initiates receptor-mediated 
endocytosis (Fig. III) (Hoffmann and Schmidt, 2004). A further domain within the 
delivery domain is the central translocation domain, which contains two hydrophobic 
helices (aa 350-372 and aa 387-412) (Fig. II). This domain is most likely responsible 
for the translocation of CNF from the endosome into the cytosol. Acidification of the 
endosome induces re-folding of the toxin to allow the insertion of the translocation 
domain into the endosome membrane (Contamin et al., 2000; Pei et al., 2001). The 
C-terminal deamidase domain (aa 720-1014) is then released into the cytosol 
(Fig. II+III) (G. Schmidt, personal communication). The auto-catalytic cleavage of the 
deamidase domain is mediated by an inherent protease domain within the delivery 
domain (Fig. II) (G. Schmidt, personal communication). A similar mechanism has 
recently been described for the glucosyltransferase domain of CGT (Egerer et al., 
2007). 
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1 190 720 1014
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Cys866
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protease
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delivery domain deamidasedomain
Fig. II: Schematic representation of the multi-domain structur of Escherichia coli cytotoxic 
necrotizing factor 1 (CNF1)
The single-chained CNF1 is an A-B toxin, which consists of an N-terminal delivery domain and a C-
terminal deamidase domain. The delivery domain harbours the receptor binding domain, the 
translocation domain, which contains two hydrophobic helices (H1, H2), and a protease domain. 
Val833, Cys866, and His881 are the crucial amino acids for the deamidase activity.
H+
endocytosis
release of 
the deamidase
domain
Rho deamidatedRho
1.
2.
3.4.
5.
RBDDD
Fig. III: Schematic representation of the proposed up-take mechanism of cytotoxic necrotizing 
factors
The receptor binding domain (RBD) binds to the receptor (1.), by which means endocytosis is initiated 
(2.). Subsequently, the endosome is acidified by an H+-ATPase (3.). Re-folding of the toxin allows the
insertion of the translocation domain into the endosome membrane. The deamidase domain (DD) is 
proteolytically cleaved into the cytosol (4.), where it deamidates cellular Rho proteins (5.).
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1.8 CNF-induced deamidation of Rho proteins 
CNF1 and CNFY catalyse the deamidation of Rho family GTP-binding proteins. 
Valine 833, cysteine 866, and histidine 881 are the three crucial amino acids for this 
activity (Fig. II), as identified by mutation studies and crystal structure analysis 
(Buetow et al., 2001; Schmidt et al., 1998). CNF1 deamidates glutamine 63 of RhoA 
or glutamine 61 of Rac1 and Cdc42 using H2O as co-substrate (Fig. IV) (Schmidt et 
al., 1997; Lerm et al., 1999). CNFY selectively deamidates RhoA (Fig. IV) (Hoffmann 
et al., 2004). Glutamine 63/61 is located within the switch II region of the Rho 
proteins and essential for GTP hydrolysis. Deamidation impairs the intrinsic as well 
as the GAP-stimulated GTPase activity (Flatau et al., 1997; Schmidt et al., 1997). 
Accordingly, CNF-induced deamidation results in constitutive activation of Rho 
proteins (Flatau et al., 1997; Schmidt et al., 1997). Deamidation of Rho proteins 
sensitises them for ubiquitinylation and subsequent degradation by the 26S 
proteasome (Boyer et al., 2006; Doye et al., 2002). This effect, however, is not 
general but cell-type-specific (Boyer et al., 2006).
Fig. IV: Deamidation of Rho proteins by cytotoxic necrotizing factors 1 and Y
CNF1 and CNFY deamidate RhoA at Gln63 using H2O as co-substrate. CNF1 deamidates the further 
substrates Rac1 and Cdc42 at Gln61.
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1.9 Cell biological consequences of Rho-protein deamidation
Deamidation, i.e., activation of RhoA, Rac1, and Cdc42 by CNF1 causes cell 
spreading, formation of actin stress fibers, membrane ruffles, and filopodia
(Hoffmann and Schmidt, 2004). Membrane ruffles and lamellipodia are required for 
phagocytosis and endocytosis. CNF1-treated epithelial cells behave like phagocytes 
and develop macropinocytotic activity (Falzano et al., 1993; Fiorentini et al., 2001). 
Furthermore, CNF1 increases the permeability of epithelial cells, thereby it disturbs
the barrier function (Gerhard et al., 1998). CNF1 induces the formation of 
multinucleated cells (Oswald et al., 1989), which has been suggested to be based on 
impaired cytokinesis with ongoing karyokinesis (Denko et al., 1997; Oswald et al., 
2005). Rac1 activation may trigger multinucleation in CNF1-treated cells (Malorni and 
Fiorentini, 2006). Furthermore, CNF1 activates Rho-dependent signalling including 
the JNK, the p38 MAP kinase, and the NF-κB pathways (Boyer et al., 2004; Lerm et 
al., 2002; Munro et al., 2004). Activation of these pathways results in the production 
of pro-inflammatory mediators, e.g., TNF-α, IL-6, IL-8, and reactive oxygen species
(ROS) (Falzano et al., 2003; Munro et al., 2004). When first identified, CNF1 was 
described as cytotoxic (Caprioli et al., 1983). Recent data, however, suggest a pro-
survival activity of CNF1. CNF1 inhibits UV-light-induced apoptosis in an NF-κB-
dependent manner (Miraglia et al., 2007). 
CNFY, which selectively deamidates RhoA, induces the formation of actin stress 
fibres and multinucleated cells (Hoffmann et al., 2004).
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2 Aims of this project
The cellular level of the immediate early gene product RhoB is low in most cell lines, 
as the rhoB promoter is suppressed by RhoA and (H/K/N)Ras. Inactivation of either 
RhoA or (H/K/N)Ras by Rho/Ras-inactivating bacterial toxins leads to “de-
suppression” of the rhoB promoter, resulting in up-regulation of RhoB. 
RhoB is also up-regulated by the cyctotoxic necrotizing factor 1 from Escherichia coli
that activates RhoA, Rac1, and Cdc42. This finding is surprising, as one must expect 
that RhoA activation by CNF1 causes suppression rather than up-regulation of RhoB. 
In this thesis, this apparent contradiction is solved. In the first part of this study, a 
new Rac1-dependent pathway is characterised that positively regulates RhoB.  
p38 MAP kinase and c-Myc are downstream effector proteins of Rac1. Their 
involvement in the CNF1-induced RhoB up-regulation is analysed in this study.
CNF1 induces the formation of prominent actin cables, lamellipodia, and filopodia, 
indicating the activation of RhoA, Rac1, and Cdc42, respectively. CNF1 further 
causes formation of multinucleated cells and cell death. In the second part of this 
study, the involvement of RhoB in the latter effects is characterised.
3 Materials and Methods 
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3 Materials and Methods 
3.1 Materials
The GST-C21 and the GST-PAK-Crib constructs were a gift of Dr. J. Collard 
(Amsterdam) (Sander et al., 1998). 
Expression vectors encoding for the constitutively active Rho GTPases myc-RhoA-
L63, myc-RhoB-L63, myc-Cdc42-L61, and myc-Rac1-L61 were a gift from P. 
Aspenstrm (Uppsala) (Aspenstrm et al., 2004).
The 3.5 kb rhoB promoter CAT construct was provided by G. Fritz (Mainz) (Fritz and 
Kaina, 1997).
Commercially obtained reagents: actinomycin D, MG132, c-Myc inhibitor ((Z,E)-5-(4-
Ethylbenzylidine)-2-thioxothiazolidin-4-one), Rac1 inhibitor (NSC23766), SB 203580 
(Calbiochem); cycloheximide, rhodamine-conjugated phalloidin (Sigma); DAPI (4',6-
diamidino-2-phenylindole) (Serva); propidium iodide (Fluka); Annexin V-Alexa fluor 
488 (Invitrogen); WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-
benzene disulfonate sodium salt), Complete-EDTA (Roche).
Antibodies: RhoA (26C4), RhoB (sc-8048) (SantaCruz); Rac1 (clone 23A8) (Upstate 
Technologies); beta-actin (AC-40) (Sigma); horseradish peroxidase conjugated 
secondary antibody, mouse (Rockland).
3.2 Toxin Preparation
In this study, recombinant toxins were applied. CNF1, CNF1-C866S, and CNFY were 
expressed as GST fusion proteins in E. coli and purified by affinity chromatography 
using glutathione-sepharose (Hoffmann et al., 2004). GST-CNF1, GST-CNF1-
C866S, and GST-CNFY were eluted from the beads using glutathione. 
3.3 Cell culture
In this study, fibroblast cell lines were applied to study the function of Rho proteins.
For functional analysis of RhoB, mouse embryonic fibroblasts (MEFs) RhoB +/- and 
RhoB -/- were applied. The role of the p38 MAP kinase was studied using MEF p38α
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WT and MEF p38α -/-. The human colon carcinoma cell lines HCT 116 p53 wild type 
and HCT 116 p53 -/- were applied to investigate the function of p53. All cell lines are 
sensitive to the cytotoxic necrotizing factors.
Fibroblasts were cultivated in Dulbecco’s modified essential medium (Biochrom, +
10 % FCS, 100 g/ml penicillin, 100 U/ml streptomycin and 1 mM sodium pyruvate) 
at 37 C and 5 % CO2. HCT 116 cells were cultivated in McCoy's 5A medium
(Biochrom, + 10 % FCS, 100 g/ml penicillin, 100 U/ml streptomycin and 1 mM 
sodium pyruvate) at 37 C and 5 % CO2. Upon confluence, cells were passaged. The 
cells were washed with phosphate buffered saline (PBS) and trypsinised. Cells were 
then suspended in full growth medium and centrifuged at 800 rpm for 5 min. Pellets 
were re-suspended in 5-10 ml full growth medium and counted using a Neubauer-
counting chamber. 105 cells were seeded per 3.5 cm2 culture dish.
3.4 Treatment of cells
Subconfluent cells were treated with CNF1 or CNFY as indicated or CNF1-C866S 
(1 g/ml). The following concentrations of the used agents were applied: MG132 
(20 M), a reversible and cell permeable inhibitor of the 26S proteasome; 
cycloheximide (1 mM), a protein synthesis inhibitor; actinomycin D (5 M), a 
transcription inhibitor; NSC23766 (60 M), a Rac1 inhibitor; (Z,E)-5-(4-
Ethylbenzylidine)-2-thioxothiazolidin-4-one (100 M) a c-Myc inhibitor; SB 203580 
(10 M), an inhibitor of the p38 MAP kinase.
3.5 Analysis of the rhoB promoter activity
The activity of the rhoB promoter was determined using a reporter gene assay. 
Chloramphenicol acetyltransferase (CAT) was used as reporter. Its expression in 
cells transfected with the 3.5 kb rhoB promoter CAT construct (rhoB subcloned into 
pCAT basic) reflects the activity of the rhoB promoter (Fritz and Kaina, 1997). 
Subconfluent NIH3T3 fibroblasts were either transiently transfected with 2 g of the
3.5 kb rhoB promoter CAT construct for 14 h (Fritz and Kaina, 1997) and then treated 
with the toxins as indicated, or cells were co-transfected with 2 g of the 3.5 kb rhoB
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promoter CAT construct and 2 g expression plasmids coding for the constitutively 
active forms of the small GTPases RhoA, RhoB, Cdc42, or Rac1. For transient 
transfection experiments, FuGENE 6 Transfection Reagent (Roche) was applied 
according to the manufacturer’s instructions. Cells were harvested and the protein
concentration of the lysates was normalised using Bradford test. The level of CAT 
expression was analysed using an enzyme-linked immunosorbent assay (CAT-Elisa
kit, Roche) according to the manufacturer’s instructions. 
3.6 RNA purification and RT-reaction
Total RNA was purified from NIH3T3 fibroblasts using the RNeasy Mini Kit (Qiagen) 
according to the manufacturer’s instructions. Briefly, ethanol was added to cell 
lysates. Lysates were applied to silica membranes to extract RNA. After DNase 
digestion, total RNA was washed and eluted with RNase free water. 
Reverse Transcription (RT)-reaction is a process, in which single-stranded RNA is 
reverse transcribed into complementary DNA (cDNA). RT-reaction was performed 
using the Omniscript RT-Kit (Qiagen) according to the manufacturer’s instructions. 
2 μg of RNA were used as template for cDNA synthesis.
3.7 Semi-quantitative real-time PCR
Real-time polymerase chain reaction (PCR) is a method that allows exponential 
amplification of DNA sequences. In this study, we applied cDNA obtained from RT-
reaction of purified total RNA to detect changes of mRNA levels. For detection of the 
synthesised PCR product, the fluorescent dye SYBR green, which specifically 
intercalates into double stranded DNA, was applied. The fluorescence intensity was
measured after each cycle to monitor the synthesis of the DNA product. For 
quantification, a threshold value for the fluorescence intensity was set. The number 
of PCR cycles required to reach this threshold (crossing point) was used to compare 
treated samples with control samples. Control samples were set to 1.0. The real-time 
PCR was performed using the QuantiTect SYBR Green PCR Kit (Qiagen) and a 
LightCycler (Roche). The cDNA obtained from the RT-reaction was diluted (1:10-
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1:100) to avoid overloading. Primers (3 M) used were: β-actin: 5’– CCT GCT TGC 
TGA TCC ACA TC– 3’ and 5’–GCA TTG CTG ACA GGA TGC AG–3’, RhoB: 5’–CCG 
AGG TAA AGC ACT TCT GC–3’ and 5’–CCG AGC ACT CGA GGT AGT CA–3’. 
3.8 Cell lysis 
After toxin treatment, cells were washed and scraped into Laemmli sample buffer. 
The obtained suspension was agitated for 10 min at 37 C and subsequently sonified 
on ice. The lysate was then incubated for 10 min at 95 C and submitted to SDS-
PAGE. 
3.9 Western blot analysis
Complete lysate proteins were separated using SDS-PAGE and subsequently 
transferred onto nitrocellulose membranes by a tank blot system. The membranes 
were blocked with 5 % (w/v) non-fat dried milk in TRIS buffered saline plus Tween-20 
(1 % (w/v)) buffer for 60 minutes. Incubation with primary antibody was conducted 
over night at 4 C, treatment with the secondary antibody for 1 h (22 C). For the 
chemoluminescence reaction, ECL Femto (Pierce) was used. All signals were 
analysed densitometrically using the KODAK 1D software and normalised to beta-
actin signals.
3.10 Rho GTPase pulldown assay 
Rho proteins cycle between an inactive, GDP-bound, and an active, GTP-bound, 
conformation. In the active conformation, they interact with their effector proteins. 
This protein interaction is used in the effector pulldown assay to determine the 
activity state of Rho proteins.
The Rho binding domain C21, encoding the N-terminal 90 amino acids of Rhotekin
(RhoA/B effector) or the CRIB domain (amino acids 56–272) of PAK (Rac1/Cdc42 
effector), were expressed as GST fusion proteins in E. coli and purified by affinity
chromatography using glutathione-sepharose. NIH3T3 fibroblasts were lysed in lysis 
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buffer (50 mM Tris pH 7.2, 150 mM NaCl, 5 mM MgCl2, 1 % NP-40, 1 mM PMSF, 5 
mM DTT, Complete-EDTA). Lysates were then added to either glutathione-bound 
GST-C21 (detection of GTP-RhoA/B) or GST-PAK-CRIB (detection of GTP-
Rac1/Cdc42) for 1 h (4C). Bound Rho GTPases were eluted by incubation with 
Laemmli sample buffer at 95 C for 10 min. Samples were submitted to SDS-PAGE 
and Western blot analysis.
3.11 Fluorescence microscopy
NIH3T3 fibroblasts seeded on coverslips were washed with PBS and subsequently
fixed in 4 % formaldehyde in phosphate buffered saline (PBS) (pH 7.4) at room 
temperature for 15 min. Cells were then washed and permeabilised with 0.3 % (w/v) 
Triton X-100 in PBS supplemented with 5 % BSA. F-actin staining was performed 
using rhodamine-conjugated phalloidin (30 g/ml) for 30 min at room temperature. 
Then, a 0.1 μg/ml solution of DAPI in PBS supplemented with 0.1 % (w/v) Tween-20 
was used for nuclei staining for 15 min at 37C. Cells were analysed by fluorescence 
microscopy using a Zeiss Axiovert 200 M.
3.12 DNA content determination by flow cytometry 
Flow Cytometry is a method that can be used to determine the DNA content of cells. 
The proportions of cells in different phases of the cell cycle can be analysed.
Furthermore, cells with an abnormal DNA content can be detected.
Cells were washed in PBS and fixed in 80 % ethanol on ice for 30 min. The cells
were then centrifuged at 1000 rpm for 5 min. RNA was removed by incubation with 
30 g/ml RNase at room temperature for 1 h. Subsequently, cells were stained with 
propidium iodide (50 μg/ml). The stained cells were analysed using a FACScan flow 
cytometer (Becton Dickinson) using CellQuest Pro software (Becton Dickinson). 
Quantitative analysis was performed using WinMDI 2.8.
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3.13 Detection of apoptosis by flow cytometry
In viable cells, the membrane component phosphatidylserine is exclusively located to 
the cytosolic side of the plasma membrane due to membrane heterogeneity.
Apoptosis is associated with loss of membrane heterogeneity. Therefore, 
phosphatidylserine becomes exposed to the outer leaflet of the plasma membrane 
during apoptosis. Annexin V specifically binds to phosphatidylserine, which becomes 
accessible only in apoptotic cells. Phosphatidylserine exposure can be detected
using Annexin V labeled with Alexa Fluor 488. 
A marker of necrosis and late apoptosis is the loss of membrane integrity, which can 
be detected in terms of propidiom iodide up-take. 
Annexin V and propidium iodide staining was assessed by flow cytometry. Cells were 
washed in phosphate-buffered saline and trypsinised. The cells were then 
centrifuged at 1000 rpm for 5 min. Subsequently, they were stained with Annexin V-
Alexa fluor 488 (2.5 l) in 50 l binding buffer (10 mM HEPES, pH 7.4, 140 mM NaCl, 
2.5 mM CaCl2, 0.1 % BSA) for 15 minutes on ice. Subsequently, 430 l of binding 
buffer were added, followed by addition of 10 l propidium iodide (50 g/ml). The 
stained cells were immediately analysed with a FACScalibur flow cytometer using 
CellQuest Pro software (Becton Dickinson). Quantitative analysis was performed 
using WinMDI 2.8.
3.14 WST-1 assay
The viability of cells was assessed using WST-1 (4-[3-(4-iodophenyl)-2-(4-
nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate (Roche)) according to the 
manufacturer’s instructions. This colorimetric assay is based on the reduction of the 
tetrazolium salt WST-1 to soluble formazan by cellular dehydrogenases, which can 
be detected by photometry. Cells were exposed to the toxins as indicated. WST-1 
was added directly into the medium. The reduction of WST-1 to formazan by 
mitochondrial dehydrogenases was quantified by photometry using a scanning 
multiwell spectrophotometer at 450 nm.
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4 Results
4.1 The rhoB promoter activity is stimulated by constitutively active Rac1 and 
CNF1
The immediate early gene rhoB has been suggested to be regulated by other Rho 
family GTP-binding proteins. While Rac1 positively regulates the activity of the rhoB
promoter, RhoA does the opposite (Fritz and Kaina, 1997). To re-investigate the 
Rho-dependent regulation of the rhoB promoter, we co-transfected NIH3T3 
fibroblasts with constitutively active forms of Rac1, Cdc42, RhoA, or RhoB and a 
3.5 kb fragment of the rhoB promoter cloned into pCAT basic for 24 h (Fig. 1A) (Fritz 
and Kaina, 1997). The expression of the reporter chloramphenicol acetyltransferase
(CAT) in transfected fibroblasts reflects the activity of the rhoB promoter. Rac1-Q61L 
increased the rhoB promoter-driven CAT expression by 1.5-fold (Fig. 1A), whereas 
RhoA-Q63L and RhoB-Q63L caused a reduction (Fig. 1A). Cdc42-Q61L did not 
affect the rhoB promoter activity (Fig. 1A). These results confirmed the former
findings of Fritz and Kaina, showing that the rhoB promoter is in fact activated by 
Rac1. RhoA and RhoB suppressed its activity. 
Cytotoxic necrotizing factor 1 (CNF1) from Escherichia coli is a protein toxin that 
deamidates and thus activates RhoA, Rac1, and Cdc42 (Hoffmann and Schmidt, 
2004). We hypothesised that Rac1 activation induced by CNF1 activates the rhoB
promoter. CNF1 increased the rhoB promoter-driven CAT expression in a 
concentration-dependent manner (Fig. 1B). In contrast, the specific activation of 
RhoA by the cytotoxic necrotizing factor from Yersinia pseudotuberculosis CNFY
hardly increased the rhoB promoter activity (Fig. 1B). These data provided further 
evidence that rhoB is positively regulated by Rac1.
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Fig. 1A: The rhoB promoter is regulated by constitutively active Rho proteins
2 g of the 3.5 kb rhoB promoter-CAT construct were co-transfected or not (mock) with 2 g of the 
expression plasmids coding for the constitutively active (ca) GTPases as indicated into NIH3T3 
fibroblasts. 24 h after transfection, cells were harvested and the CAT protein level was quantified. The 
CAT level of control (mock) cells was set to 1.0. Results displayed are the mean + S.D. of three 
independent experiments.
Fig. 1B: CNF1 activates the rhoB promoter 
Fibroblasts were transfected with 2 g of the 3.5 kb rhoB promoter CAT construct for 14 h. Cells were 
treated with increasing concentrations of CNF1 or CNFY or left untreated for 7 h. Cells were harvested 
and the CAT protein level was quantified. The CAT level of untreated cells was set to 1.0. Results 
displayed are the mean + S.D. of three independent experiments.
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4.2 CNF1-induced RhoB up-regulation depends on mRNA and protein de novo
synthesis and its deamidase activity
To check, whether the CNF1-induced activation of the rhoB promoter was reflected 
by an up-regulation of rhoB mRNA, semi-quantitative real-time RT-PCR was applied
(Fig. 2A). CNF1 increased the rhoB mRNA level up to 7-fold (Fig. 2A). In contrast, 
CNFY failed to do so (< 3-fold). The CNF1-induced RhoB up-regulation was further 
analysed at the protein level (Fig. 2B). CNF1 increased the RhoB protein level in a 
concentration-dependent manner. Both actinomycin D, an inhibitor of mRNA 
synthesis, and cycloheximide, an inhibitor of protein synthesis, abolished this effect 
(Fig. 2B). Thus, CNF1-induced RhoB up-regulation was based on both mRNA and 
protein de novo synthesis.
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Fig. 2A: CNF1-induces up-regulation of rhoB mRNA
Fibroblasts were exposed to increasing concentrations of CNF1 or CNFY for 4 h. Total mRNA was 
prepared and submitted to real-time RT-PCR. rhoB signals were normalised to beta-actin signals. The 
control level was set to 1.0. Results displayed are the mean + S.D. of three independent experiments.
4 Results
- 20 -
Lipopolysaccharide (LPS) has recently been shown to cause up-regulation of RhoB 
in dendritic cells (Kamon et al., 2006). LPS is a cell wall component of gram-negative 
bacteria, which is released after microbial cell death. CNF1 applied in this study was
prepared from E. coli and purified as GST fusion protein. Thus, LPS may be a 
contamination of the CNF preparation. To exclude that LPS was the trigger of RhoB 
up-regulation, fibroblasts were treated with the deamidase-deficient mutant of CNF1, 
CNF1-C866S (Blumenthal et al., 2007). CNF1-C866S failed to cause a strong RhoB 
up-regulation (Fig. 2C). RhoB up-regulation was therefore based on the deamidation 
of Rho proteins. It was not due to an enzyme-independent activity of the toxin or 
based on LPS-contamination. Minor activation of the rhoB promoter and up-
regulation of rhoB mRNA by CNFY may be based on LPS (Fig. 1B+2A).
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Fig. 2B: CNF1-induced RhoB up-regulation is inhibited by actinomycin D and cycloheximide
Fibroblasts were treated with either actinomycin D (5 μM) or cycloheximide (1 mM) or left untreated for 
1 h. CNF1 was then added as indicated and incubation continued for 4 h. Cells were lysed and 
submitted to immunoblot against RhoB and beta-actin. Western blots from representative experiments 
are shown (n = 3).
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Fig. 2C: CNF1-induced RhoB up-regulation depends on its deamidase activity
Fibroblasts were treated with increasing concentrations of CNF1 or CNF1-C866S. After 4 h, cells were 
lysed and submitted to immunoblot against RhoB and beta-actin. Western blots from representative 
experiments are shown (n = 3).
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4.3 CNF1 causes up-regulation of RhoB via Rac1 and c-Myc 
CNF1 and CNFY-induced deamidation of Rho proteins results in their activation. 
Thus, we assessed the state of activity of RhoA, RhoB, Rac1, and Cdc42 in 
fibroblasts treated with increasing concentrations of CNF1 or CNFY for 4 h. Effector 
pulldown assays using the GTPase binding domain of Rhotekin or the CRIB domain 
of PAK to precipitate active RhoA/RhoB or Rac1/Cdc42, respectively, were 
performed (Fig. 3A). CNF1 induced RhoB up-regulation as well as RhoB activation 
(Fig. 3A). In contrast, CNFY hardly increased the RhoB protein level. The activity of 
RhoB, however, increased in CNFY-treated fibroblasts (Fig. 3A). This finding 
suggests that RhoB was deamidated by CNFY. RhoA was activated by both CNF1 
and CNFY in fibroblasts, with CNFY being more efficient (Fig. 3A). The total level of 
RhoA was not affected by the toxins. Furthermore, CNF1 but not CNFY activated 
Rac1 and Cdc42, indicating their deamidation. The total levels of Rac1 and Cdc42 
slightly decreased in a toxin concentration-dependent manner (Fig. 3A). Thus, the 
activity of Rac1 correlated with the up-regulation of RhoB in CNF1-treated fibroblasts 
(Fig. 3A). 
0 0.01 0.1 1 0.01 0.1        1 [g/ml]
RhoB
active
total
active
total
Rac1
active
total
RhoA
CNF1 CNFY
active
total
Cdc42
Fig. 3A: Activation of Rho proteins by CNF1 and CNFY
NIH3T3 fibroblasts were treated with increasing concentrations of CNF1 for 4 h. Cell lysates were 
submitted to either Rhotekin (RhoA, RhoB) or PAK (Rac1, Cdc42) pulldown assay to assess the 
activity. Total and precipitated Rho proteins were analysed by Western blot analysis with the indicated 
antibodies. Western blots from representative experiments are shown (n = 3).
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We investigated next, whether active Rac1 was indeed the trigger of the CNF1-
induced up-regulation of RhoB. To this end, we applied NSC23766, an inhibitor of 
Rac1. NSC23766 inhibits Rac1 by blocking its binding to the GEF proteins Tiam and 
Trio (Gao et al., 2004). In cells treated with NSC23766, the CNF1-induced activation 
of Rac1 was clearly reduced (Fig. 3B). The reduced Rac1 activation was reflected by 
reduced RhoB up-regulation (Fig. 3B). Correspondingly, NSC23766 reduced the 
CNF1-induced activation of the rhoB promoter (Fig. 3C), confirming that RhoB up-
regulation was in fact based on Rac1 activation.
NSC23766 inhibits the interaction of Rac1 with GEF proteins, which in turn are 
activated by growth factors. The CNF1-induced Rac1 activation and RhoB up-
regulation may thus depend on the presence of growth factors in the serum. In 
serum-starved fibroblasts, both Rac1 activation and RhoB up-regulation were
reduced compared to serum-cultured fibroblasts (Fig. 3B). Accordingly, the CNF1-
induced increase of the rhoB mRNA was reduced in the absence of serum (Fig. 3D). 
CNF1-induced Rac1 activation and subsequent up-regulation of RhoB was thus 
enhanced in the presence of serum. These results suggested that the presence of 
growth factors facilitated Rac1 activation and subsequent RhoB up-regulation. 
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NSC23766 ‒ ‒ ‒ ‒ ‒ ‒ + + +
+ + + + + +‒ ‒ ‒
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Fig. 3B: CNF1-induced RhoB up-regulation is Rac1-dependent and reduced in serum-starved 
fibroblasts
Fibroblasts were either serum-starved for 24 h, or pre-treated with NSC23766 (60 μM) for 1 h, or left 
untreated. Cells were exposed to increasing concentrations of CNF1 for 4 h. Cell lysates were 
submitted to PAK pulldown assay to assess the activity of Rac1 and Cdc42. Total and precipitated
Rho proteins were analysed by Western blot analysis with the indicated antibodies. Western blots from 
representative experiments are shown (n = 3).
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CNF1-induced activation of Cdc42 was enhanced in the presence of NSC23766 and 
also in serum-starved compared to serum-cultured fibroblasts (Fig. 3B). This finding 
showed that NSC23766 blocked Rac1 but not Cdc42 activation. 
Rac1 positively regulates the transcription factor c-Myc (Boureux et al., 2005). c-Myc 
is up-regulated in response to PDGF in a Rac1-dependent manner in fibroblasts. 
Hence, CNF1 induces the expression of c-Myc (Chiariello et al., 2001). We 
hypothesised that c-Myc played a role in the CNF1-mediated RhoB up-regulation. 
Therefore, we treated fibroblasts with the c-Myc inhibitor (Z,E)-5-(4-Ethylbenzylidine)-
2-thioxothiazolidin-4-one (Fig. 2F+H). This inhibitor specifically blocks the c-Myc-Max 
interaction, thereby preventing the transactivation of c-Myc target gene expression
(Yin et al., 2003). The c-Myc inhibitor reduced both the CNF1-induced activation of 
the rhoB promoter and RhoB up-regulation (Fig. 3C+E). These findings showed that 
RhoB was up-regulated in a c-Myc-dependent manner.
Fig. 3C: CNF1-induced activation of the rhoB promoter is responsive to inhibition of Rac1 and 
c-Myc
Fibroblasts were transfected with 2 g of the 3.5 kb rhoB promoter CAT construct for 14 h. Cells were 
treated with either NSC23766 (60 μM, empty bars) or (Z,E)-5-(4-Ethylbenzylidine)-2-thioxothiazolidin-
4-one (c-Myc inhibitor, 100 M, striped bars) or left untreated (filled bars) for 1 h. CNF1 (0.1 g/ml) 
was then added and incubation continued for 7 h. Cells were harvested and the CAT protein level was 
quantified. The CAT level of untreated cells was set to 1.0. Results displayed are the mean + S.D. of 
three independent experiments.
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Fig. 3D: CNF1-induced up-regulation of rhoB mRNA is reduced in serum-starved fibroblasts
Fibroblasts were either serum-starved (empty bars) or not (filled bars) for 24 h. Cells were then 
exposed to CNF1 (1 g/ml) for 4 h. Total mRNA was prepared and submitted to real-time RT-PCR. 
rhoB signals were normalised to beta-actin signals. The control level was set to 1.0. Results displayed 
are the mean + S.D. of three independent experiments.
Fig. 3E: CNF1-induced RhoB up-regulation is c-Myc-dependent
Fibroblasts, either 1 h pre-treated or not with (Z,E)-5-(4-Ethylbenzylidine)-2-thioxothiazolidin-4-one (c-
Myc inhibitor, 100 M), were exposed to CNF1 as indicated. After 4 h, cells were lysed and submitted 
to immunoblot against RhoB and beta-actin. Western blots from representative experiments are 
shown (n = 3).
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4.4. The p38 MAP kinase negatively regulates the CNF1-induced RhoB up-
regulation   
The p38 mitogen-activated protein (MAP) kinase is activated in CNF1-treated cells 
(Brest et al., 2004). We checked, whether p38 played a role in the CNF1-induced 
RhoB up-regulation. RhoB up-regulation was analysed in NIH3T3 fibroblasts pre-
treated with the pharmacological inhibitor of p38 MAP kinase, SB 203580 (Fig. 4A). 
SB 203580 enhanced the CNF1-induced RhoB up-regulation (Fig. 4A). In this line, 
SB 203580 also enhanced the CNF1-induced up-regulation of the rhoB mRNA level 
and the activation of the rhoB promoter (Fig. 4B+C). These findings suggested a 
suppressive role of p38 in the transcriptional activation of rhoB in CNF1-treated cells. 
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Fig. 4A: CNF1-induced RhoB up-regulation is enhanced by SB 203580
Fibroblasts were pre-treated with SB 203580 (10 μM) or left untreated for 1 h. CNF1 was then added 
as indicated and incubation continued for 4 h. Cells were lysed and submitted to immunoblot against 
RhoB and beta-actin. Signals were analysed densitometrically. RhoB signals were normalised to beta-
actin signals. The control level was set to 1.0. Results displayed are the mean + S.D. of three 
independent experiments.
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Fig. 4B: CNF1-induced up-regulation of rhoB mRNA is enhanced by SB 203580
Fibroblasts were pre-treated with SB 203580 (10 μM) or left untreated for 1 h. Cells were then 
exposed to increasing concentrations of CNF1 for 4 h. Total mRNA was prepared and submitted to 
real-time RT-PCR. rhoB signals were normalised to beta-actin signals. The control level was set to 
1.0. Results displayed are the mean + S.D. of three independent experiments.
Fig. 4C: CNF1-induced activation of the rhoB promoter is enhanced by SB 203580
Fibroblasts were transfected with 2 g of the 3.5 kb rhoB promoter CAT construct for 14 h. Cells were 
pre-treated with SB 203580 (10 μM) or left untreated for 1 h. CNF1 was then added as indicated and 
incubation continued for 7 h. Cells were harvested and the CAT protein level was quantified. The CAT 
level of untreated cells was set to 1.0. Results displayed are the mean + S.D. of three independent 
experiments.
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This finding was confirmed using a p38α MAP kinase -/- mouse embryonic fibroblast 
(MEF) cell line. p38α is the most abundant of the four isoforms of p38 MAP kinase. 
The applied MEFs do not express the other isoforms β, γ and, δ. Thus, the p38α -/-
cells represent a cell line devoid of p38 MAP kinase signalling. In p38α -/- MEFs, the 
CNF1-induced RhoB up-regulation was enhanced compared to wild type cells 
(Fig. 5A). Accordingly, up-regulation of rhoB mRNA and activation of the rhoB
promoter were enhanced in p38α -/- MEFs compared to wildtype cells (Fig. 5B+C).
These data are consistent with the above results obtained applying the inhibitor in 
NIH3T3 fibroblasts. Wild type MEFs pre-treated with SB 203580 also exhibited 
enhanced RhoB up-regulation, comparable to that observed in p38α -/- MEFs 
(Fig. 5D). The inhibitor was without effect in CNF1-treated p38α -/- fibroblasts, 
confirming its specificity (Fig. 5D). In conclusion, the p38 MAP kinase pathway
suppressed RhoB up-regulation in CNF1-treated fibroblasts.
Fig. 5A: CNF1-induced up-regulation of RhoB protein is enhanced in p38α -/- ME fibroblasts
WT or p38α -/- ME fibroblasts were exposed to the indicated concentrations of CNF1 for 4 h. Cells 
were lysed and submitted to immunoblot against RhoB and beta-actin. Western blots from 
representative experiments are shown (n = 3).
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Fig. 5B: CNF1-induced up-regulation of rhoB mRNA is enhanced in p38α -/- ME fibroblasts
WT (filled bars) or p38α -/- (empty bars) ME fibroblasts were exposed to CNF1 (0.1 g/ml) or left 
untreated for 4 h. Total mRNA was prepared and submitted to real-time RT-PCR. rhoB signals were 
normalised to beta-actin signals. The control level was set to 1.0. Results displayed are the mean + 
S.D. of three independent experiments.
MEF WT
MEF p38α -/-
untreated CNF1
0
1
2
3
4
R
el
. r
ho
B
 p
ro
m
ot
er
 a
ct
iv
ity
R
el
. r
ho
B
 p
ro
m
ot
er
 a
ct
iv
ity
Fig. 5C: CNF1-induced activation of the rhoB promoter is enhanced in p38α -/- ME fibroblasts
WT (filled bars) or p38α -/- (empty bars) ME fibroblasts were transfected with 2 g of the 3.5 kb rhoB
promoter CAT construct for 14 h. CNF1 (0.1 g/ml) was then added and incubation continued for 7 h.  
Cells were harvested and the CAT protein level was quantified. The CAT level of untreated cells was 
set to 1.0. Results displayed are the mean + S.D. of three independent experiments.
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Fig. 5D: SB 203580 does not affect CNF1-induced RhoB up-regulation in p38α -/- fibroblasts
WT or p38α -/- ME fibroblasts were pre-treated with SB 203580 (10 μM) or left untreated for 1 h. CNF1 
was then added as indicated and incubation continued for 4 h. Cells were lysed and submitted to 
immunoblot against RhoB and beta-actin. Signals were analysed densitometrically. RhoB signals were 
normalised to beta-actin signals. The control levels were set to 1.0. Results displayed are the mean 
+ S.D. of three independent experiments.
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4.5 RhoB is proteasomally degraded in CNF1-treated fibroblasts
RhoB is rapidly up-regulated upon stress stimulation and rapidly degraded, exhibiting 
a half-life period of 2 h (Lebowitz et al., 1995). Rho proteins are degraded in a 
proteasome-dependent manner in CNF1-treated cells (Doye et. al, 2002). We 
hypothesised that RhoB is degraded in CNF1-treated cells in a proteasome-
dependent manner as well. To this end, cells were treated with CNF1 for 4 h (Fig. 6). 
Cycloheximide (CHX) was then applied and the RhoB level monitored for further 3 h. 
After addition of CHX, up-regulated RhoB was almost completely degraded within 1 h 
(Fig. 6). The half-life period was < 1 h. To check, whether RhoB was proteasomally 
degraded, fibroblasts were incubated with the proteasome inhibitor MG132 prior to 
CNF1 exposure (Fig. 6). RhoB was not degraded after addition of CHX in the 
presence of MG132, indicating that RhoB degradation was predominantly
proteasome-dependent.
Fig. 6: RhoB is degraded in a proteasome-dependent manner in fibroblasts exposed to CNF1
Fibroblasts were pre-treated with MG132 (20 μM) or left untreated for 1 h. Cells were then exposed to 
CNF1 (1 g/ml) for 4 h. Subsequently, cycloheximide (1 mM) was added and incubation continued for 
the periods indicated. Cells were lysed and submitted to immunoblot against RhoB and beta-actin. 
Western blots from representative experiments are shown (n = 3).
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4.6 RhoB up-regulation is persistent in CNF1-treated fibroblasts 
Up-regulation of immediate early gene products such as c-fos and c-jun is transient 
(Chen et al., 2001). To check, whether RhoB up-regulation was transient, the cellular 
protein level of RhoB was analysed after long-term treatment with CNF1 (Fig. 7). 
Western-Blot analysis revealed that the RhoB level was elevated for at least 48 h, 
independent of the applied CNF1 concentration (Fig. 7). In contrast, the cellular 
levels of Rac1 and RhoA in CNF1-treated cells were comparable to the levels in 
untreated fibroblasts after 24 h and 48 h (Fig. 7). In conclusion, although exhibiting a 
short half-life period (Fig. 6), the up-regulation of RhoB induced by CNF1 was 
persistent. Apparently, RhoB up-regulation was permanently triggered in CNF1-
treated cells. 
Fig. 7: RhoB up-regulation is persistent in CNF1-treated fibroblasts
Fibroblasts were treated with increasing concentrations of CNF1 for either 24 h or 48 h. Cells were 
lysed and submitted to immunoblot against RhoB, RhoA, Rac1, and beta-actin. Western blots from 
representative experiments are shown (n = 3).
0 0.01 0.1 1 0 0.01 0.1      1 [g/ml] CNF1 
beta-actin
RhoB
RhoA
Rac1
24 h 48 h
4 Results
- 32 -
4.7 CNF1 induces multinucleation and polyploidy in NIH3T3 fibroblasts 
The most striking feature of CNF1-treatment of cultured cells is the formation of 
multinuclei (Oswald et al., 1989). We analysed CNF1-induced multinucleation in 
fibroblasts by fluorescence microscopy (Fig. 8A+B). The majority (70 %) of fibroblasts 
was multinucleated after toxin-treatment for 24 h (Fig. 8B). 
untreated CNF1
Fig. 8A: CNF1 induces multinucleation and stress fiber formation
Fibroblasts were exposed to CNF1 (1 g/ml) or left untreated for 24 h. Cells were fixed and stained 
with rhodamine-phalloidin (30 g/ml) and DAPI (0.1 μg/ml) to visualise F-actin and nuclei, respectively.
Arrows indicate multinucleated cells (upper panels: phase contrast; lower panels; fluorescence 
images). 
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Fig. 8B: CNF1 induces multinucleation in a concentration-dependent manner
Fibroblasts were exposed to increasing concentrations of CNF1 for 24 h. The cells were fixed and 
stained with DAPI. Nuclei were visualised by fluorescence microscopy and multinucleation determined 
by counting. 200 cells were analysed for each experimental condition. Results displayed are the mean
 S.D. of three independent experiments.
Multinucleation implies an increased DNA content and is thus reflected by polyploidy. 
Polyploidy was analysed using flow cytometry applying the nuclear dye propidium 
iodide (PI) (Fig. 9A+B). CNF1 caused polyploidy in a time-dependent manner in 
fibroblasts (Fig. 9B). CNF1-treatment decreased the 2N population in a time-
dependent manner (Fig. 9B). The 4N population transiently increased and 
subsequently diminished in response to CNF1. The percentage of cells with 8N DNA 
content increased in a time-dependent manner from 0 % to 50 %, reflecting CNF1-
induced polyploidy. Note that further cells with a DNA content of 4N and > 4N – 8N 
were possibly multinucleated, explaining the lower number of polyploid cells (50 %) 
compared to multinucleated cells (70 %) (Fig. 8B+9B). Polyploidy depended on the 
deamidase activity, as deamidase-deficient CNF1-C866S failed to induce it (Fig. 9A). 
In untreated fibroblasts, the 2N population increased from 35 % to 70 % in a time-
dependent manner, while the 4N population decreased from 30 % to 15 % (Fig. 9B). 
An 8N population was not observed. The redistribution between 2N and 4N after 72 h 
was likely due to density inhibition (Fig. 9B). 
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Fig. 9A: CNF1-induced polyploidy depends on its deamidase activity
Fibroblasts were exposed to either CNF1 (0.1 g/ml) or CNF1-C866S (1 g/ml) or left untreated for the 
indicated periods. After staining with propidium iodide (50 μg/ml), the DNA content of the cells was 
analysed by flow cytometry. 104 cells were analysed for each experimental condition. Histograms from 
representative experiments are shown (n = 3).
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Fig. 9B: CNF1 induces polyploidy in a time-dependent manner
Fibroblasts were either exposed to CNF1 (0.1 g/ml) (●) or left untreated (■) for the indicated periods. 
The cells were then stained with propidium iodide and analysed for DNA content by flow cytometry. 
104 cells were analysed for each experimental condition. Results displayed are the mean of three 
independent experiments.
To confirm that CNF1 blocks cell division without affecting nuclear division, we 
quantified the number of cells in untreated or in CNF1-treated samples in a time-
dependent manner. The cell number of CNF1-treated fibroblasts remained almost 
unchanged, indicating that cell division was blocked (Fig. 10). In contrast, the number 
of untreated (proliferating) cells increased up to 48 h, until cell division was blocked 
by density inhibition (Fig. 10). Interestingly, the viability (determined by WST-1 assay) 
and the protein content (determined by Bradford test) comparably increased in 
CNF1-treated and untreated (proliferating) cells (Fig. 10). Thus, CNF1 caused an 
apparently increased viability and protein content of cells, while it inhibited cell 
division. In proliferating cells, the increased viability and protein content were based 
on an increased number of cells.
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Fig. 10: CNF1 blocks cell division but increases viability and protein content of fibroblasts
Fibroblasts were exposed to CNF1 (0.1 g/ml) (●) or left untreated (■) for the indicated periods. The 
cell number (upper panel) was determined using the Neubauer counting chamber. The cell number of 
untreated cells (0 h) was set to 1.0. Cell viability (left panel) was assessed by the WST-1 assay. The 
activity of untreated cells (0 h) was set to 1.0. The total protein content (right panel) was assessed by 
the Bradford test. The protein content of untreated cells (0 h) was set to 1.0. Results displayed are the 
mean of three independent experiments.
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4.8 CNF1-induced polyploidy is p53-independent
The tumor suppressor p53 has been shown to induce cell cycle arrest and apoptosis
in tetraploid cells (“tetraploidy checkpoint”) (Andreassen et al., 2001). We 
hypothesised that p53 suppresses CNF1-induced polyploidy. Therefore, we utilised 
the human colon carcinoma cell lines HCT 116 wild type and HCT 116 p53 -/-. CNF1 
caused an increase of the 8N and a decrease of the 2N and 4N populations in both 
wild type and p53 -/- cells in a time-dependent manner (Fig. 11). CNF1-induced 
polyploidy was comparable in p53 -/- and wild type cells (Fig. 11). Thus, CNF1-
induced polyploidy was not suppressed by p53.  
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Fig. 11: CNF1-induced polyploidy is p53-independent
WT (■) and p53 -/- (●) HCTs were exposed to CNF1 (0.1 g/ml) for the indicated periods. The cells 
were then stained with propidium iodide and analysed for DNA content by flow cytometry. 104 cells 
were analysed for each experimental condition. Results displayed are the mean of three independent 
experiments.
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4.9 p38 MAP kinase positively regulates the CNF1-induced polyploidy
p38 MAP kinase promotes cell cycle arrest in response to stress stimuli to prevent 
polyploidy (Mikule et al., 2007). We assumed that p38 MAP kinase suppresses 
CNF1-induced polyploidy. Surprisingly, inhibition of p38 by SB 203580 reduced the 
8N population in CNF1-treated fibroblasts (Fig. 12A+B). To confirm this notion, 
polyploidy was analysed in CNF1-treated wild type and p38α -/- fibroblasts (Fig. 12C). 
In line with our former observation, CNF1-induced polyploidy was less pronounced in 
p38α -/- cells compared to wild type cells. Thus, p38 MAP kinase promoted rather 
than suppressed polyploidy in CNF1-treated fibroblasts. 
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Fig. 12A: CNF1-induced polyploidy is reduced by SB 203580
Fibroblasts were pre-treated with SB 203580 (20 μM) or left untreated for 1 h. CNF1 (0.1 g/ml) was 
then added and incubation continued for 24 h. The cells were subsequently stained with propidium 
iodide and analysed for DNA content by flow cytometry. 104 cells were analysed for each experimental 
condition. Histograms from representative experiments are shown (n = 3).
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Fig. 12B: CNF1-induced polyploidy is reduced by SB 203580
NIH3T3 fibroblasts were pre-treated with SB 203580 (10 μM) or left untreated for 1 h. CNF1 
(0.1 g/ml) was then added and incubation continued for 24 h. The cells were subsequently stained 
with propidium iodide and analysed for DNA content by flow cytometry. 104 cells were analysed for 
each experimental condition. Results displayed are the mean + S.D. of three independent 
experiments.
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Fig. 12C: CNF1-induced polyploidy is reduced in p38α -/- fibroblasts
WT or p38α -/- fibroblasts were exposed to CNF1 (0.1 g/ml) or left untreated for 24 h. The cells were 
then stained with propidium iodide and analysed for DNA content by flow cytometry. 104 cells were 
analysed for each experimental condition. Results displayed are the mean + S.D. of three independent 
experiments.
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4.10 RhoB suppresses CNF1-induced polyploidy
RhoB suppresses radiation-induced polyploidy in NIH3T3 fibroblasts (Milia et al., 
2005). We hypothesised that RhoB suppresses CNF1-induced polyploidy as well. To 
this end, we exposed NIH3T3 fibroblasts, RhoB +/-, and RhoB -/- MEFs to CNF1 or 
CNF1-C866S for 24 h (Fig. 13A). CNF1 but not its inactive mutant CNF1-C866S 
caused a decrease of the 2N and an increase of the 8N population (exemplarily
shown for RhoB -/- MEFs) (Fig. 13A). CNF1-induced polyploidy was further analysed 
in NIH3T3 fibroblasts, RhoB +/-, and RhoB -/- MEFs in a concentration-dependent 
manner after 24 h (Fig. 13B). CNF1 more efficiently increased the 8N population in 
RhoB -/- cells than in RhoB +/- or in NIH3T3 fibroblasts. This effect was reflected by 
a stronger decrease of the 2N and the 4N population in RhoB -/- cells compared to 
RhoB +/- and NIH3T3 fibroblasts (Fig. 13B). Thus, the efficacy of CNF1 to cause 
polyploidy was enhanced in the absence of RhoB, leading to the conclusion that 
RhoB suppresses polyploidy.
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Fig. 13A: CNF1 induces polyploidy in RhoB -/- ME fibroblasts
RhoB -/- MEFs were exposed to either CNF1 (0.1 g/ml) or CNF1-C866S (1 g/ml) or left untreated 
for 24 h. The cells were then stained with propidium iodide and analysed for DNA content by flow 
cytometry. 104 cells were analysed for each experimental condition. Histograms from representative 
experiments are shown (n = 3).
4 Results
- 41 -
0 0.01 0.1 1
0
10
20
30
40
50
60
70
80
2N
 c
el
ls
 p
er
 to
ta
l c
el
ls
 [%
]
c (CNF1) [g/ml]
0 0.01 0.1 1
0
10
20
30
40
50
60
70
80
8N
 c
el
ls
 p
er
 to
ta
l c
el
ls
 [%
]
c (CNF1) [g/ml]
0 0.01 0.1 1
0
10
20
30
40
50
60
70
80
4N
 c
el
ls
 p
er
 to
ta
l c
el
ls
 [%
]
c (CNF1) [g/ml]
2N 4N
8N
● RhoB +/-
■ NIH3T3
▲ RhoB -/-
● RhoB +/-
■ NIH3T3
▲ RhoB -/-
● RhoB +/-
■ NIH3T3
▲ RhoB -/-
2N
 c
el
ls
 p
er
 to
ta
l c
el
ls
 [%
]
8N
 c
el
ls
 p
er
 to
ta
l c
el
ls
 [%
]
4N
 c
el
ls
 p
er
 to
ta
l c
el
ls
 [%
]
Fig. 13B: CNF1-induced polyploidy is enhanced in RhoB -/- ME fibroblasts
NIH3T3 (■), RhoB +/- (●), and RhoB -/- (▲) fibroblasts were exposed to increasing concentrations of 
CNF1 for 24 h. The cells were then stained with propidium iodide and analysed for DNA content by 
flow cytometry. 104 cells were analysed for each experimental condition. Results displayed are the 
mean of three independent experiments.
We showed that p38 suppressed RhoB (Fig. 4+5). Therefore, we assumed that the 
p38-dependent enhancement of polyploidy was based on RhoB suppression. 
Thus, polyploidy (8N DNA content) was determined in RhoB -/- cells either in the 
presence or in the absence of SB 203580 (Fig. 13C). SB 203580 reduced the CNF1-
induced polyploidy in NIH3T3 fibroblasts but not in RhoB -/- cells (Fig. 13C). Thus, 
the enhanced CNF1-induced polyploidy in SB 203580-treated or p38α -/- cells likely 
depended on RhoB suppression. 
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Fig. 13C: SB 203580 does not affect CNF1-induced polyploidy in RhoB -/- ME fibroblasts
NIH3T3 (filled bars) and RhoB -/- (empty bars) fibroblasts were pre-treated with SB 203580 (10 μM) or 
left untreated for 1 h. CNF1 (0.1 g/ml) was then added and incubation continued for 24 h. The cells 
were subsequently stained with propidium iodide and analysed for DNA content by flow cytometry. 104
cells were analysed for each experimental condition. Results displayed are the mean + S.D. of three 
independent experiments.
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4.11 RhoB promotes survival of CNF1-treated cells
RhoB has been implicated to regulate cell survival as well as cell death pathways. 
Multinucleation and polyploidy are frequently associated with cell death. We 
investigated, whether CNF1 causes cell death in fibroblasts and whether RhoB is 
involved. Cell death was analysed as ratio of cells with subG1 (hypodiploid) DNA 
content per total cells. The DNA content of CNF1-treated NIH3T3, RhoB +/- and 
RhoB -/- cells was determined by flow cytometry. Long-term incubation (48 h) of 
fibroblasts with CNF1 caused an increased number of subG1 cells (< 2N) (Fig. 14A). 
RhoB -/- cells were more sensitive to CNF1-induced cell death than RhoB +/- cells 
and NIH3T3 fibroblasts (Fig. 14A). Apparently, the absence of RhoB sensitised cells 
to CNF1-treated cell death. 
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Fig. 14A: CNF1 increases the SubG1 population in RhoB -/- ME fibroblasts
NIH3T3, RhoB +/-, and RhoB -/- ME fibroblasts were exposed to CNF1 (0.1 g/ml) or left untreated for 
48 h. The cells were then stained with propidium iodide and analysed for DNA content by flow 
cytometry. 104 cells were analysed for each experimental condition. Results displayed are the mean 
+ S.D. of three independent experiments.
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To confirm this finding and further characterise CNF1-induced cell death, the number 
of Annexin V- and PI-positive cells was determined using flow cytometry. Annexin V-
staining indicates phosphatidylserine exposure and thus the loss of membrane 
heterogeneity, a marker of early apoptotic cells. PI-staining reflects a loss of 
membrane integrity, a marker of late apoptotic or necrotic cells. CNF1 increased the 
number of Annexin V-positive (early apoptotic) and Annexin V + PI- positive (late 
apoptotic) RhoB -/- cells in a concentration-dependent manner after 48 h (Fig. 14B). 
In contrast, CNF1 hardly induced apoptosis in NIH3T3 and RhoB +/- (Fig. 14B). The 
absence of RhoB sensitised cells to CNF1-induced apoptotic cell death. Thus, these 
data suggested a pro-survival function of RhoB in CNF1-treated cells.
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Fig. 14B: CNF1 causes phosphatidylserine exposure in RhoB -/- ME fibroblasts
NIH3T3, RhoB +/-, or RhoB -/- fibroblasts were treated with the indicated concentrations of CNF1 for 
48 h. Cells were then stained with Annexin V-Alexa Fluor 488 and propidium iodide. Subsequent 
FACS analysis was performed by FACScalibur using the software CellQuest Pro (Becton Dickinson). 
Quantitative analysis was performed using WinMDI 2.8.
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5 Discussion
5.1 Activation of rhoB by CNF1
RhoB is the only member of the Rho subfamily that is transcriptionally regulated. It is 
induced by cellular stress, e.g., genotoxic agents, and therefore classified as 
immediate early gene product (Jhner and Hunter, 1991). The basal expression level
of RhoB is low in cells due to the RhoA- and (H/K/N)Ras-dependent suppression of
the rhoB promoter activity (Jiang et al., 2004). Accordingly, inactivation of RhoA or 
(H/K/N)Ras by either geranylgeranyl-transferase/farnesyl-transferase inhibitors 
(Stamatakis et al., 2002) or Rho/Ras-inactivating bacterial protein toxins (Gerhard et 
al., 2005; Huelsenbeck et al., 2007) causes “de-suppression”, i.e., up-regulation of 
RhoB.
Transcriptional activation of rhoB also occurs in response to platelet-derived growth 
factor (PDGF) and epidermal growth factor (EGF) (Jhner and Hunter, 1991). These 
growth factors activate Rac1 (Ridley et al., 1992). In fact, a Rac1-dependent 
activation of the rhoB promoter has been proposed (Fritz and Kaina, 1997). Thus, we 
hypothesised that Rac1 positively regulates RhoB. Initially, we confirmed that 
overexpression of (constitutively active) Rac1-Q61L caused an activation of the rhoB
promoter (Fig. 1A). To analyse the Rac1-dependent RhoB up-regulation in detail, we 
applied the Rac1-activating cytotoxic necrotizing factor 1 (CNF1) from E. coli. CNF1 
activated the rhoB promoter as well (Fig. 1B). CNF1 also activates Cdc42. In contrast 
to Rac1-Q61L, Cdc42-Q61L did not activate the rhoB promoter (Fig. 1A). Therefore, 
CNF1-induced activation of the rhoB promoter was most probably a consequence of 
Rac1 activation. Expectedly, RhoA-Q63L suppressed the rhoB promoter activity (Fig.
1A). Treatment with the isomeric CNFY from Y. pseudotuberculosis, which specifically 
activates RhoA, hardly increased the rhoB promoter activity (Fig. 1B). In conclusion, 
Rac1 but neither RhoA nor Cdc42 activates the rhoB promoter.
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5.2 Up-regulation of rhoB mRNA and RhoB protein by CNF1
CNF1-induced activation of the rhoB promoter was reflected by an up-regulation of 
rhoB mRNA and RhoB protein (Fig. 2A+B). RhoB up-regulation was responsive to 
inhibition by actinomycin D and cycloheximide (Fig. 2B). Thus, RhoB up-regulation 
required both mRNA and protein de novo synthesis. The responsiveness to 
actinomycin D further indicated that changes in rhoB mRNA stability played a minor 
role at best in RhoB up-regulation. In CNF1-treated cells, RhoB is thus subject to 
linear regulation. An increase in rhoB promoter activity is reflected by increases of 
the mRNA and the protein level. Changes in mRNA or protein stability play minor 
roles. A comparable regulation has been described for IL-8 (Kuwahara et al., 2006). 
To our knowledge, this is the first detailed study on the regulation of RhoB 
encompassing regulation from the promoter to the protein level. 
CNF1-induced activation of the rhoB promoter as well as RhoB protein up-regulation 
were susceptible to inhibition by NSC23766, an inhibitor of Rac1 (Fig. 3B+C). Thus,
Rac1 activation was indeed the trigger of CNF1-induced RhoB up-regulation (Fig. V). 
NSC23766 inhibits the interaction of Rac1 with its GEF proteins, which in turn are 
activated by growth factors. We hypothesised that CNF1-induced Rac1 activation 
and subsequent RhoB up-regulation required the presence of growth factors in the 
serum. In serum-starved fibroblasts, both Rac1 activation and RhoB up-regulation 
were indeed reduced (Fig. 3B). Deamidation of Rho GTPases by CNF1 per se is 
supposed to be sufficient for their constitutive activation. Our findings, however,
indicate that GEF-driven GTP-loading is still required and critical for short-term 
activation of Rac1 by CNF1 (4 h). Long-term activation of Rac1 by CNF1 seems not 
to require GEF-driven GTP loading. After 24 h, up-regulation of RhoB occurred 
independent of the presence of serum (data not shown). Spontaneous GTP loading 
is likely sufficient for long-term activation (auto-enhancing mechanism). In conclusion, 
deamidation is not sufficient for rapid Rac1 activation. The requirement for activation 
by GEFs challenges the paradigm that GTPase-deficient Rho proteins are per se
constitutively active. 
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5.3 Role of c-Myc in CNF1-induced RhoB up-regulation 
Rac1 regulates the transactivation of c-Myc in a JNK-dependent manner (Iavarone et 
al., 2003). We hypothesised that JNK and c-Myc are involved in the CNF1-induced 
up-regulation of RhoB. Both RhoB up-regulation and rhoB promoter activation were
reduced by the c-Myc inhibitor (Z,E)-5-(4-Ethylbenzylidine)-2-thioxothiazolidin-4-one 
in CNF1-treated cells (Fig. 3C+E). This inhibitor blocks the interaction of c-Myc with 
its interaction partner Max. As a heterodimer, c-Myc-Max binds to DNA to activate 
gene expression (Yin et al., 2003). c-Myc activation is apparently an important 
intermediate step in the Rac1-dependent RhoB up-regulation (Fig. V). The rhoB
promoter, however, does not possess the c-Myc-Max consensus sequence 
CAC(G/A)TG (Fritz and Kaina, 1997). Thus, c-Myc does not likely cause a direct 
transactivation of rhoB, suggesting the involvement of further transcription factors. As 
RhoB is up-regulated in CNF1-treated fibroblasts rapidly, c-Myc rather recruits a 
basal transcription factor instead of regulating rhoB via transactivation of a further 
inducible transcription factor. c-Myc has been shown to interact with the CCAAT-box 
binding, basal transcription factor NF-Y without affecting its ability to bind to DNA 
(Izumi et al., 2001). The rhoB promoter possesses a CCAAT-box, which is critical for 
rhoB activation induced by UV-light (Fritz and Kaina, 2001). Furthermore, NF-Y has 
been suggested to bind to the rhoB promoter (Fritz and Kaina, 2001). Thus, it is 
conceivable that c-Myc regulates the rhoB promoter activity via NF-Y. 
5.4 Role of p38 MAP kinase in CNF1-induced RhoB up-regulation
p38 MAP kinase regulates gene expression by distinct mechanisms: (i) 
transcriptional, via phosphorylation of transcription factors that regulate promoter 
activity; (ii) posttranscriptional, via alteration of mRNA stability or by affecting the 
mRNA translation into protein (Schieven, 2005). Rac1 and Cdc42 positively regulate 
p38 MAP kinase (Kyriakis and Avruch, 2001). Accordingly, CNF1 has been shown to 
activate p38 (Munro et al., 2004). We observed that RhoB up-regulation was 
enhanced by inhibition of p38 with its pharmacological inhibitor SB 203580 (Fig. 4A-
C). Accordingly, RhoB up-regulation was enhanced in p38α -/- MEF compared to WT 
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MEF (Fig. 5A-C). These findings were reflected at the rhoB promoter level, as the 
rhoB promoter activity was enhanced by inhibition or in the absence of p38 
(Fig. 4C+5C). SB 203580 was without effect in CNF1-treated p38α -/- MEF, 
confirming the specificity of SB 203580 (Fig. 5D). Thus, we conclude that p38 
negatively regulates the CNF1-induced RhoB up-regulation at the transcriptional 
rather than post-transcriptional level (Fig. V). This is a striking finding, as p38 usually 
activates gene transcription, as shown for ATF-2 (Raingeaud et al., 1996). p38 MAP 
kinase, however, negatively regulates the level and activity of ERK (Page et al., 
2001).
JNK
CNF1
Rac1
rhoB promoter
p38
c-Myc X+ Y
Fig. V: Model of RhoB up-regulation by CNF1
RhoB is up-regulated by CNF1 in a Rac1-dependent manner by transcriptional activation. c-Myc is 
activated by CNF1 in a Rac1-JNK-dependent manner. Activation of c-Myc is an important intermediate 
step in the Rac1-dependent RhoB up-regulation. A basal transcription factor (X) is likely recruited by c-
Myc to cause activation of the rhoB promoter. CNF1 causes activation of p38 MAP kinase in a Rac1-
dependent manner. p38 negatively regulates the CNF1-induced RhoB up-regulation at the 
transcriptional level. Thereby, an inhibitory transcription factor (Y) may be involved.
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5.5 State of activity of RhoB in CNF1-treated cells
Rho proteins exert their biological functions only in the active, GTP-bound, state. We 
found that CNF1-induced RhoB up-regulation correlated with its activation (Fig. 3A). 
Even though CNFY failed to cause RhoB up-regulation, it caused an activation of 
RhoB (Fig. 3B). This finding suggests that RhoB may be a yet non-identified cellular 
substrate of CNFY. 
Both RhoB mRNA and protein are labile, with half-life periods of approximately 20 
min and 2 h, respectively (Fritz et al., 1995; Lebowitz et al., 1995). Inhibition of the 
26S proteasome by MG132 showed that RhoB is degraded in CNF1-treated cells in a 
proteasome-dependent manner (Fig. 6). In CNF1-treated cells, the half-life period of
RhoB was < 1 h (Fig. 6). Thus, the half-life period was reduced in CNF1-treated cells 
compared to cells treated with FTI (Lebowitz et al., 1995). Deamidation by CNF1 
sensitises Rho proteins to proteasomal degradation (Doye et al., 2002). RhoB has 
been shown to be deamidated by CNF1 in vitro (G. Schmidt, personal 
communication). The enhanced degradation of RhoB in CNF1-treated cells provides 
a hint that RhoB may not only be an in vitro but also a cellular substrate of CNF1. 
As opposed to other immediate early gene products, the up-regulation of RhoB by 
CNF1 was not transient but long-lasting in CNF1-treated cells (Fig. 7). This finding 
was remarkable, since its half-life period was < 1 h in CNF1-treated cells. The 
persistent RhoB up-regulation is likely based on permanent Rac1 activation and thus 
permanent activation of the rhoB promoter.
5.6 CNF-induced polyploidy
CNFs cause multinucleation of cultured cells (Oswald et al., 1989). This effect is 
based on their ability to modulate the eukaryotic cell cycle, leading to their 
classification as cyclomodulins (Oswald et al., 2005). We observed multinuclei in 
fibroblasts exposed to CNF1. Multinucleation is associated with an increased DNA 
content (polyploidy). Binucleated cells, however, appear as cells with 4N DNA 
content and cannot be distinguished from cells in the G2- or M-phase of the cell 
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cycle. 8N cells occur in response to CNF1 and its homologue CNF2 (Denko et al.,
1997; Nougayrede et al., 2005). We determined the number of 8N cells to quantify 
polyploidy. These cells are at least binucleated and are rarely observed in untreated 
fibroblasts. Initially, we confirmed that CNF1 increased the 8N population in 
fibroblasts, reflecting multinucleation (Fig. 9A+B). The formation of multinucleated 
cells suggests failure in cytokinesis. Although the formation of multinuclei is 
described as hallmark of CNF-treatment, CNFs have been suggested to promote cell 
proliferation (Nougayrede et al., 2005). Cell proliferation, however, is characterised 
by ongoing cellular division, resulting in an increasing cell number. To clarify this 
contradiction, we determined cell proliferation by two distinct methods: 1. 
Determination of the cell number; 2. Application of the generally accepted 
proliferation assay WST-1, which measures the viability in terms of activity of cellular 
dehydrogenases. The cell number remained almost constant after CNF1-exposure, 
while it increased in the untreated (proliferating) cell population (Fig. 10). Thus, CNF1 
blocks cell proliferation. The increase in viability (WST-1 assay) of untreated and 
CNF1-treated cells was comparable (Fig. 10). Thus, in CNF1-treated cells, the 
viability per cell increased. This may be due to an increase in cell size. In untreated 
cells, the increased viability reflected the increased cell number (Fig. 10). Thus, the 
WST-1 assay misleadingly indicates that proliferation continues during CNF1-
treatment. The activity of cellular dehydrogenases does not necessarily correlate with 
cell proliferation. Therefore, the WST-1 assay is not suitable to determine 
proliferation of cells exposed to cyclomodulins. In conclusion, CNF1 blocks cell 
proliferation. Inhibition of cytokinesis with ongoing karyokinesis causes polyploidy.
It has been proposed that CNF1-induced multinucleation is based on Rac1 activation 
(Malorni and Fiorentini, 2006). The homologue CNFY from Yersinia 
pseudotuberculosis, which selectively deamidates RhoA, however, also causes 
polyploidy (Hoffmann et al., 2004). This led us to the hypothesis that RhoA rather 
than Rac1 deamidation is critical for CNF1-induced polyploidy. RhoA plays a critical 
role during cytokinesis (Fig. VI) (Maddox and Oegema, 2003). During the first step of 
cytokinesis furrow ingression occurs (Fig. VI). RhoA is activated by its GEF Ect2. 
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Active, GTP-bound, RhoA, which is localised to the plasma membrane, is responsible 
for the formation of the contractile ring. Furthermore, RhoA blocks the actin-severing 
activity of cofilin during furrow ingression (Fig. VI). Completion of cytokinesis, 
however, requires RhoA inactivation induced by Mgc GAP (Fig. VI). Mgc GAP is 
localised to the interzonal microtubule bundles that form between the segregating 
chromosomes. Contraction of the cleavage furrow around the microtubules brings 
RhoA into the vacinity of Mgc GAP, leading to RhoA inactivation. RhoA inactivation in 
turn is accompanied by activation of cofilin. Cofilin causes disassembly of the 
contractile ring to terminate cell division (Fig. VI) (Maddox and Oegema, 2003). We 
therefore propose that CNFs impair cytokinesis by blocking the Mgc-dependent 
RhoA inactivation (Fig. VI). As a consequence, cofilin remains inactive and is 
therefore incapable of completing cytokinesis, resulting in polyploidy. In this line, 
disruption of Mgc GAP has been shown to cause polyploidy (Minoshima et al., 2003).
Furrow ingression Cytokinesis completion
RhoA
GTP
Ect2 (GEF)
contractile ring
formationcofilin
Mgc (GAP)
RhoA
GDP
Ect2 (GEF)
cofilin
Mgc (GAP)
disassembly of 
actin filaments
CNF1
Fig. VI: Model of CNF1-induced polyploidy
During the first step of cytokinesis (furrow ingression) RhoA is kept in the active, GTP-bound,
conformation by its GEF Ect2. RhoA, which is localised to the plasma membrane, is responsible for 
the formation of the contractile ring. Contraction of the cleavage furrow leads to RhoA inactivation by 
Mgc GAP. RhoA inactivation in turn causes cofilin activation. Disassembly of actin filaments induced 
by cofilin completes cytokinesis. CNF1 blocks the Mgc-stimulated RhoA inactivation. It thereby inhibits 
cytokinesis completion, leading to polyploidy (adapted from Maddox and Oegema, 2003).  
5 Discussion
- 53 -
5.7 Involvement of p53 in the CNF1-induced polyploidy
After failed cytokinesis, tetraploid cells can enter the G1 phase (Rieder and Maiato, 
2004). p53 has been suggested to cause G1-arrest or apoptosis of tetraploid cells to 
prevent genomic instability (Andreassen et al., 2001). This “tetraploidy checkpoint” 
provides an opportunity to eliminate potentially dangerous cells. We hypothesised 
that p53 suppresses CNF1-induced polyploidy (Table II). CNF1 increased the 
number of 8N cells in HCT 116 wild type and HCT 116 p53 -/- with comparable 
kinetics (Fig. 11). Thus, tetraploidy per se does not cause a p53-dependent G1-arrest 
or apoptosis. Several other studies also provide evidence that tetraploid or polyploid 
cells are capable of proliferation, challenging the idea of a tetraploidy checkpoint 
(Guidotti et al., 2003; Storchova and Pellman, 2004). In uroepithelial cells, CNF1 has 
been suggested to cause a G2/M-arrest, corresponding to G1-arrest of tetraploid 
cells (Falzano et al., 2006). We observed the occurrence of a population of cells with 
8N DNA content in several cell lines including NIH3T3 fibroblasts, ME fibroblasts, and 
the human colon carcinoma cell line HCT 116 (Fig. 9B+11+12C). In J774A.1 
macrophages and in the epithelial cell line Vero, however, CNF1 caused an increase 
of the 4N population without an occurrence of an 8N population (data not shown).
Thus, a possible cell cycle arrest in response to CNF1 appears to be cell type 
specific but does not likely depend on p53.
Table II: Effect of inhibition of p53, p38, and RhoB on CNF1-induced polyploidy
↓
↓
↓
effect on 
polyploidy
(literature)
↑↑RhoB
↓↑p38
↔↑p53
observed effect on 
polyploidy
(after inhibition/genetic
deletion)
expected effect on 
polyploidy
(after inhibition/genetic
deletion)
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5.8 Involvement of the p38 MAP kinase in the CNF1-induced polyploidy
p38 MAP kinase is induced by cellular stress, such as ultraviolet radiation, osmotic 
shock, or pro-inflammatory cytokines (Schieven, 2005; Seo et al., 2004). p38 blocks
cell proliferation and tumorigenesis by causing senescence or apoptosis (Han and 
Sun, 2007). We hypothesised that p38 suppresses CNF1-induced polyploidy 
(Table II). Inhibition of p38 by SB 203580 suppressed CNF1-induced polyploidy 
(Fig. 12A+B). Accordingly, polyploidy was reduced in p38α MAP kinase -/- cells 
compared to wild type cells (Fig. 12C). Thus, p38 promotes rather than suppresses 
CNF1-induced polyploidy (Table II). p38 triggered neither cell cycle arrest nor 
apoptosis in CNF1-treated fibroblasts. This finding is contrary to the general anti-
proliferative and pro-apoptotic role of p38. We hypothesise that this unexpected 
effect of p38 is based on its suppressive effect on RhoB (Fig. 4+5).
5.9 Role of RhoB in the CNF1-induced polyploidy
We suggested above that RhoA deamidation causes cytokinesis failure, resulting in 
polyploidy. The RhoA homologue RhoB protects fibroblasts from radiation-induced 
multinucleation associated with abberant nuclei (Milia et al., 2005). In response to 
CNF1-treatment, multinucleated cells exhibited nuclei of equal size but no abberant 
nuclei (micronulei). RhoB, however, also suppressed the CNF1-induced type of 
multinucleation (reflected by polyploidy) (Fig. 13B). The p38-dependent 
enhancement of polyploidy we observed is most likely based on RhoB suppression, 
as inhibition of p38 was without effect on RhoB -/- cells (Fig. 13C). 
RhoB has been proposed to protract the radiation induced G2 arrest, by which 
means it suppresses centrosome overduplication (Milia et al., 2005). Centrosomes 
are key regulators of the mitotic spindle. Centrosome overduplication contributes to 
the assembly of multipolar spindles, thereby disturbing division of chromosomes
(Sato et al., 2000). Centrosome abnormalities are often associated with the 
occurrence of abberant nuclei rather than polyploidy (Pihan et al., 2003). Thus, this 
model is not suitable to explain the suppressive effect of RhoB in CNF1-induced 
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polyploidy. A further role of centrosomes in cytokinesis completion has been 
described (Piel et al., 2001). After formation of the cleavage furrow, one centrosome 
moves into the intracellular bridge. This effect is required for cytokinesis completion 
(abscission) (Piel et al., 2001). The Rho-kinase p160ROCK, a downstream effector of 
RhoB, is involved in the regulation of centrosomes (Milia et al., 2005). p160ROCK is
required for centrosome positioning (Chevrier et al., 2002). RhoB may control the 
movement of the centrosome into the intracellular bridge in a p160ROCK-dependent 
manner, thereby promoting abscission. 
5.10 Role of RhoB in survival of CNF1-treated cells
RhoB might be involved in the physiological arrest- and repair-mechanisms after 
stress stimuli. As a janus-faced protein, RhoB appears to be involved in the decision 
of the cell to undergo DNA-repair or apoptosis (Fritz and Kaina, 2000). Recent data 
have highlighted the protective role of CNF1 against UV-B-induced apoptosis 
(Miraglia et al., 2007). The Rac-stimulated PI3K/Akt pathway that in turn leads to NF-
κB-dependent Bcl-2 expression is essential for the protective effect (Miraglia et al., 
2007). RhoB activates NF-κB (Rodriguez et al., 2007), which in turn promotes the 
transcription of pro-survival factors such as Bcl-2 (Buchholz et al., 2005).
Furthermore, RhoB controls trafficking of the pro-survival protein kinase Akt (Adini et 
al., 2003). We hypothesised that RhoB plays an essential role in the regulation of 
survival in CNF1-treated cells. CNF1 caused cell death in the absence of RhoB 
(Fig. 14A+B), suggesting a pro-survival function of RhoB.
We cannot rule out that polyploidy per se causes cell death. The pro-survival function 
of RhoB in CNF1-treated cells may thus be based on inhibition of polyploidy 
(Fig. VII).
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5.11 Conclusions
We characterised a new Rac1-dependent pathway, which causes up-regulation of 
RhoB. The pathway involves c-Myc as an acivator and p38 MAP kinase as a 
suppressor (Fig. V). Based on published data we expected that inhibition of RhoB, 
p38, and p53 enhances CNF1-induced polyploidy (Table II). We found that p53 has 
no effect on CNF1-induced polyploidy (Fig. VII). p38 promotes polyploidy due to 
suppression of RhoB. RhoB negatively regulates polyploidy (Fig. VII).  
CNF1 is an important virulence factor of uropathgenic E. coli (Rippere-Lampe et al.,
2001). Inhibition of cytokinesis by CNF1 likely inhibits renewal of epithelial cells. Lack 
of renewal may result in prolonged colonisation and persistence of uropathogenic 
bacteria in the epithel. RhoB may be required for the survival of the mammalian 
target cells.
polyploidy         
RhoA
RhoB
CNF1
Rac1
p38 MAP kinase
cell death         
?
p53
Fig. VII: Role of p53, p38, and RhoB in CNF1-induced polyploidy
CNF1-induced deamidation of RhoA causes polyploidy. Activation of Rac1 by CNF1 causes RhoB up-
regulation and p38 MAP kinase activation. p53, which is downstream of p38 (Ganem and Pellman,
2007), has no effect on CNF1-induced polyploidy. p38 promotes polyploidy due to suppression of 
RhoB. RhoB negatively regulates polyploidy. Polyploidy may result in cell death. RhoB suppresses cell 
death in CNF1-treated cells.
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We showed that c-Myc and p38 MAP kinase are involved in the Rac1-dependent 
RhoB up-regulation. The molecular mechanism of the regulation of the rhoB
promoter remains to be solved. Based on sequence analysis of the rhoB promoter, 
diverse sequences for the binding sites of transcription factors were identified 
(Fig. VIII) (Fritz and Kaina, 1997). Besides a TATA box, the rhoB promoter contains 
consensus sequences for SP1, p53, AP-2, AP-4, PEA3, XRE, and CF1. The 
identification of those transcription factors involved in the activation/inactivation of the 
rhoB promoter will give hints on signalling pathways involved. Four deletion mutants 
of the rhoB promoter construct are available to perform this analysis (Fig. VIII).
CAT
5-noncoding region of rhoB reporter
+1-1900bp -1000 +410-934
CAT-2
-575
CAT-3
-147
CAT-4
-80
TATA-
CAT
TATACAAT
CAT-1
p53AP-2p53 AP-4PEA3XRECF1 SP1
Fig. VIII: Schematic representation of the deletion mutants of the rhoB promoter construct with 
putative binding sites for transcription factors
The rhoB promoter contains consensus sequences for SP1, p53, AP-2, AP-4, PEA3, XRE, and CF1.
Four deletion mutants of the rhoB promoter construct are available to identify transcription factors, 
which are involved in the regulation of rhoB, by reporter gene assay.
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7 Abbreviations
aa amino acid 
AP-2 activating protein-2
AP-4 activating protein-4
ATF-2 activating transcription factor-2
ATP adenosine triphosphate
Bcl-2 B-cell lymphoma 2
CF1 common factor 1
BSA bovine serum albumin
C3bot Clostridium botulinum C3 exoenzyme
C21 Rho-binding domain of Rhotekin
CAT chloramphenicol acetyltransferase
cDNA complementary DNA
CGT clostridial glucosylating toxin
CHX cycloheximide
CNF1 Escherichia coli cytotoxic necrotizing factor 1
CNFY Yersinia pseudotuberculosis cytotoxic necrotizing Y
Da Dalton
DAPI 4',6-diamidino-2-phenylindole
DD deamidase domain
DNA deoxyribonucleic acid
DNT Bordetella dermonecrotic toxin
E. coli Escherichia coli
EDTA ethylenediaminetetraacetic acid
EGF epidermal growth factor
ERK extracellular signal-regulated kinase
FACS fluorescence activated cell sorting
FCS fetal Calf Serum
Fig. figure
FT farnesyl-transferase
FTI farnesyl-transferase inhibitor
GAP GTPase activating protein
GDI guanine nucleotide dissociation inhibitor
GDP guanosine diphosphate
GEF guanine nucleotide exchange factor
GGT geranylgeranyl-transferase
GGTI geranylgeranyl-transferase inhibitor
GST glutathione S-transferase
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GTP guanosine triphosphate
HCT human colon carcinoma cells
HeLa cervical cancer cells (taken from Henrietta Lacks)
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
HSPG heparan sulfate proteoglycan
IL interleukine
JNK c-Jun N-terminal kinases
kb kilo base pairs
LPA lysophosphatidic acid
LPS lipopolysaccharide
MAP mitogen-activated protein
MEF mouse embryonic fibroblast
MKK mitogen-activated protein kinase kinase
mRNA messenger RNA
NAD nicotinamid adenin dinucleotide
NF-κB nuclear factor-κB
NF-Y nuclear factor-Y
PAGE polyacrylamide gel electrophoresis
PAK p21-activated kinase
PBS phospate-buffered saline
PCR polymerase chain reaction
PDGF platelet-derived growth factor
PI propidium iodide
PMSF phenylmethylsulphonyl fluoride
Ras Rat sarcoma
RBD receptor binding domain
Rel. relative
Rho Ras homologous
RhoB-F farnesylated RhoB
RhoB-GG geranylgeranylated RhoB
RNA ribonucleic acid
ROCK Rho-associated kinase
ROS reactive oxygen species
rpm rotations per minute
RT reverse transcription
S.D. standard deviation
SDS sodium dodecyl sulfate
SP1 specificity protein 1
TcdA Clostridium difficile toxin A 
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TcsL Clostridium sordellii lethal toxin
TMD transmembrane domain
TNF-α tumor necrosis factor-α
Tris tris(hydroxymethyl)aminomethane
UPEC uro-pathogenic Escherichia coli
UV ultraviolet
WST-1 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-
benzene disulfonate sodium salt
WT wild type
w/v weight/volume
XRE xenobiotic response element
SI units and non-SI units accepted for use with SI were applied.
The one-letter and three-letter abbreviation codes for amino acids were used. 
The bases of the DNA were abbreviated according to the IUB (International Union of
Biochemistry) tentative rules.
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